Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 226 of 226 entries
Sorted by: Best Match Show Resources per page
An Analysis of the Predictors of Major Bleeding After Transcatheter Aortic Valve Transplantation Using the National Inpatient Sample (2015-2018).

Cureus

Khan H, Gilani A, Qayum I, Khattak T, Haq F, Zahid Anwar M, Khan MA, Asjad SJ, Abbas S, Inayat A.
PMID: 34336511
Cureus. 2021 Jun 29;13(6):e16022. doi: 10.7759/cureus.16022. eCollection 2021 Jun.

Background Transcatheter aortic valve replacement (TAVR) is now a common procedure to treat and improve quality of life, clinical outcomes, and self-sufficiency in high-risk patients with aortic stenosis, and its use has been expanding rapidly in younger and low-risk...

Cite
Khan H, Gilani A, Qayum I, et al. An Analysis of the Predictors of Major Bleeding After Transcatheter Aortic Valve Transplantation Using the National Inpatient Sample (2015-2018). Cureus. 2021;13(6):e16022doi: 10.7759/cureus.16022.
Khan, H., Gilani, A., Qayum, I., Khattak, T., Haq, F., Zahid Anwar, M., Khan, M. A., Asjad, S. J., Abbas, S., & Inayat, A. (2021). An Analysis of the Predictors of Major Bleeding After Transcatheter Aortic Valve Transplantation Using the National Inpatient Sample (2015-2018). Cureus, 13(6), e16022. https://doi.org/10.7759/cureus.16022
Khan, Henna, et al. "An Analysis of the Predictors of Major Bleeding After Transcatheter Aortic Valve Transplantation Using the National Inpatient Sample (2015-2018)." Cureus vol. 13,6 (2021): e16022. doi: https://doi.org/10.7759/cureus.16022
Khan H, Gilani A, Qayum I, Khattak T, Haq F, Zahid Anwar M, Khan MA, Asjad SJ, Abbas S, Inayat A. An Analysis of the Predictors of Major Bleeding After Transcatheter Aortic Valve Transplantation Using the National Inpatient Sample (2015-2018). Cureus. 2021 Jun 29;13(6):e16022. doi: 10.7759/cureus.16022. eCollection 2021 Jun. PMID: 34336511; PMCID: PMC8319189.
Copy Download .nbib Format: NLM
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities.

Seminars in immunology

Galani IE, Andreakos E.
PMID: 34815163
Semin Immunol. 2021 Nov 09;101522. doi: 10.1016/j.smim.2021.101522. Epub 2021 Nov 09.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged pathogen that has caused coronavirus disease 2019 (COVID-19), the worst pandemic of our times leading to tremendous loss of human life and unprecedented measures of social distancing. COVID-19...

Cite
Galani IE, Andreakos E. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Semin Immunol. 2021;101522doi: 10.1016/j.smim.2021.101522.
Galani, I. E., & Andreakos, E. (2021). Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Seminars in immunology, 101522. https://doi.org/10.1016/j.smim.2021.101522
Galani, Ioanna-Evdokia, and Andreakos, Evangelos. "Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities." Seminars in immunology vol. (2021): 101522. doi: https://doi.org/10.1016/j.smim.2021.101522
Galani IE, Andreakos E. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Semin Immunol. 2021 Nov 09;101522. doi: 10.1016/j.smim.2021.101522. Epub 2021 Nov 09. PMID: 34815163; PMCID: PMC8576141.
Copy Download .nbib Format: NLM
Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.

Thrombosis research

Oakes M, Arastu A, Kato C, Somers J, Holly HD, Elstrott BK, Dy GW, Kohs TCL, Patel RR, McCarty OJT, DeLoughery TG, Milano C, Raghunathan V, Shatzel JJ.
PMID: 34592628
Thromb Res. 2021 Sep 20;207:96-98. doi: 10.1016/j.thromres.2021.09.005. Epub 2021 Sep 20.

Erythrocytosis is a well-recognized consequence of exogenous testosterone, however its prevalence and contributions to thrombosis remain unknown in the context of gender-affirming hormonal therapy. We undertook a retrospective study of transgender and non-binary (TGNB) adults receiving exogenous testosterone. In...

Cite
Oakes M, Arastu A, Kato C, et al. Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone. Thromb Res. 2021;207:96-98doi: 10.1016/j.thromres.2021.09.005.
Oakes, M., Arastu, A., Kato, C., Somers, J., Holly, H. D., Elstrott, B. K., Dy, G. W., Kohs, T. C. L., Patel, R. R., McCarty, O. J. T., DeLoughery, T. G., Milano, C., Raghunathan, V., & Shatzel, J. J. (2021). Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone. Thrombosis research, 20796-98. https://doi.org/10.1016/j.thromres.2021.09.005
Oakes, Michael, et al. "Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone." Thrombosis research vol. 207 (2021): 96-98. doi: https://doi.org/10.1016/j.thromres.2021.09.005
Oakes M, Arastu A, Kato C, Somers J, Holly HD, Elstrott BK, Dy GW, Kohs TCL, Patel RR, McCarty OJT, DeLoughery TG, Milano C, Raghunathan V, Shatzel JJ. Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone. Thromb Res. 2021 Sep 20;207:96-98. doi: 10.1016/j.thromres.2021.09.005. Epub 2021 Sep 20. PMID: 34592628.
Copy Download .nbib Format: NLM
Evaluation of Body Composition in Paediatric Osteogenesis Imperfecta.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Gilani M, Shepherd S, Nichols B, Gerasimidis K, Choong Wong S, Mason A.
PMID: 33582031
J Clin Densitom. 2021 Jan 30; doi: 10.1016/j.jocd.2021.01.012. Epub 2021 Jan 30.

Osteogenesis Imperfecta (OI) is a skeletal disorder characterised by a predisposition to recurrent fractures and bone deformities. Clinically OI is defined by features such as short stature, however, less is known regarding body composition. Assess body composition, both lean...

Cite
Gilani M, Shepherd S, Nichols B, et al. Evaluation of Body Composition in Paediatric Osteogenesis Imperfecta. J Clin Densitom. 2021;doi: 10.1016/j.jocd.2021.01.012.
Gilani, M., Shepherd, S., Nichols, B., Gerasimidis, K., Choong Wong, S., & Mason, A. (2021). Evaluation of Body Composition in Paediatric Osteogenesis Imperfecta. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, . https://doi.org/10.1016/j.jocd.2021.01.012
Gilani, Misha, et al. "Evaluation of Body Composition in Paediatric Osteogenesis Imperfecta." Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry vol. (2021). doi: https://doi.org/10.1016/j.jocd.2021.01.012
Gilani M, Shepherd S, Nichols B, Gerasimidis K, Choong Wong S, Mason A. Evaluation of Body Composition in Paediatric Osteogenesis Imperfecta. J Clin Densitom. 2021 Jan 30; doi: 10.1016/j.jocd.2021.01.012. Epub 2021 Jan 30. PMID: 33582031.
Copy Download .nbib Format: NLM
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.

Cell metabolism

Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y, Hoffman K, Bhardwaj P, Piloco P, Rubio-Navarro A, Uhl S, Carrau L, Houhgton S, Redmond D, Shukla AP, Goyal P, Brown KA, tenOever BR, Alonso LC, Schwartz RE, Schenck EJ, Safford MM, Lo JC.
PMID: 34879241
Cell Metab. 2021 Dec 07;33(12):2484. doi: 10.1016/j.cmet.2021.10.014.

No abstract available.

Cite
Reiterer M, Rajan M, Gómez-Banoy N, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021;33(12):2484doi: 10.1016/j.cmet.2021.10.014.
Reiterer, M., Rajan, M., Gómez-Banoy, N., Lau, J. D., Gomez-Escobar, L. G., Ma, L., Gilani, A., Alvarez-Mulett, S., Sholle, E. T., Chandar, V., Bram, Y., Hoffman, K., Bhardwaj, P., Piloco, P., Rubio-Navarro, A., Uhl, S., Carrau, L., Houhgton, S., Redmond, D., Shukla, A. P., Goyal, P., Brown, K. A., tenOever, B. R., Alonso, L. C., Schwartz, R. E., Schenck, E. J., Safford, M. M., & Lo, J. C. (2021). Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell metabolism, 33(12), 2484. https://doi.org/10.1016/j.cmet.2021.10.014
Reiterer, Moritz, et al. "Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2." Cell metabolism vol. 33,12 (2021): 2484. doi: https://doi.org/10.1016/j.cmet.2021.10.014
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y, Hoffman K, Bhardwaj P, Piloco P, Rubio-Navarro A, Uhl S, Carrau L, Houhgton S, Redmond D, Shukla AP, Goyal P, Brown KA, tenOever BR, Alonso LC, Schwartz RE, Schenck EJ, Safford MM, Lo JC. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021 Dec 07;33(12):2484. doi: 10.1016/j.cmet.2021.10.014. PMID: 34879241; PMCID: PMC8650200.
Copy Download .nbib Format: NLM
Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus.

Molecular biology reports

Vankwani S, Ansari A, Azhar A, Galani S.
PMID: 34807379
Mol Biol Rep. 2022 Jan;49(1):421-432. doi: 10.1007/s11033-021-06889-7. Epub 2021 Nov 22.

INTRODUCTION: The antibiotic resistance has become a major threat to global health. The combinatorial use of two or more compounds to develop a new formulation may overcome the emerging cases of drug resistance. Moringa oleifera has been utilized as...

Cite
Vankwani S, Ansari A, Azhar A, et al. Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus. Mol Biol Rep. 2021;49(1):421-432doi: 10.1007/s11033-021-06889-7.
Vankwani, S., Ansari, A., Azhar, A., & Galani, S. (2022). Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus. Molecular biology reports, 49(1), 421-432. https://doi.org/10.1007/s11033-021-06889-7
Vankwani, Soma, et al. "Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus." Molecular biology reports vol. 49,1 (2022): 421-432. doi: https://doi.org/10.1007/s11033-021-06889-7
Vankwani S, Ansari A, Azhar A, Galani S. Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus. Mol Biol Rep. 2022 Jan;49(1):421-432. doi: 10.1007/s11033-021-06889-7. Epub 2021 Nov 22. PMID: 34807379.
Copy Download .nbib Format: NLM
Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience.

Endocrine, metabolic & immune disorders drug targets

Casella C, Morandi R, Verrengia A, Galani A, Molfino S, Cuka D, Groppo G, Cappelli C, Portolani N.
PMID: 33380308
Endocr Metab Immune Disord Drug Targets. 2021;21(11):2028-2034. doi: 10.2174/1871530321666201230111911.

BACKGROUND: The existence of a link between Graves' Disease (GD) and Thyroid Cancer (TC) has long been investigated, however a clear pathogenic correlation is yet to be found.OBJECTIVE: We verified the presence of TC in patients submitted to surgery...

Cite
Casella C, Morandi R, Verrengia A, et al. Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2028-2034doi: 10.2174/1871530321666201230111911.
Casella, C., Morandi, R., Verrengia, A., Galani, A., Molfino, S., Cuka, D., Groppo, G., Cappelli, C., & Portolani, N. (2021). Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience. Endocrine, metabolic & immune disorders drug targets, 21(11), 2028-2034. https://doi.org/10.2174/1871530321666201230111911
Casella, Claudio, et al. "Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience." Endocrine, metabolic & immune disorders drug targets vol. 21,11 (2021): 2028-2034. doi: https://doi.org/10.2174/1871530321666201230111911
Casella C, Morandi R, Verrengia A, Galani A, Molfino S, Cuka D, Groppo G, Cappelli C, Portolani N. Thyroid Cancer and Nodules in Graves' Disease: A Single Center Experience. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2028-2034. doi: 10.2174/1871530321666201230111911. PMID: 33380308.
Copy Download .nbib Format: NLM
Neonatal Bowel Obstruction by Pseudolymphoma: A Case Report.

Cureus

Galani A, Zikopoulos A, Mastora E, Zikopoulos K.
PMID: 33842123
Cureus. 2021 Mar 06;13(3):e13746. doi: 10.7759/cureus.13746.

Interstitial obstruction in newborn infants can be caused by several factors such as malrotation, meconium plug syndrome, meconium ileus, Hirschsprung's disease, atresia and stenosis. Neonates who have been diagnosed with an interstitial obstruction are in need of immediate treatment;...

Cite
Galani A, Zikopoulos A, Mastora E, et al. Neonatal Bowel Obstruction by Pseudolymphoma: A Case Report. Cureus. 2021;13(3):e13746doi: 10.7759/cureus.13746.
Galani, A., Zikopoulos, A., Mastora, E., & Zikopoulos, K. (2021). Neonatal Bowel Obstruction by Pseudolymphoma: A Case Report. Cureus, 13(3), e13746. https://doi.org/10.7759/cureus.13746
Galani, Apostolia, et al. "Neonatal Bowel Obstruction by Pseudolymphoma: A Case Report." Cureus vol. 13,3 (2021): e13746. doi: https://doi.org/10.7759/cureus.13746
Galani A, Zikopoulos A, Mastora E, Zikopoulos K. Neonatal Bowel Obstruction by Pseudolymphoma: A Case Report. Cureus. 2021 Mar 06;13(3):e13746. doi: 10.7759/cureus.13746. PMID: 33842123; PMCID: PMC8021925.
Copy Download .nbib Format: NLM
Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery.

Pharmaceutical development and technology

Bahrainian S, Rouini M, Gilani K.
PMID: 33896355
Pharm Dev Technol. 2021 Jul;26(6):647-660. doi: 10.1080/10837450.2021.1915331. Epub 2021 May 05.

The aim of the current study was to achieve a dry powder formulation of vancomycin by spray drying whilst evaluating the effect of pH and excipient type and percentage used in formulation on particle characteristics and aerosolization performance. A...

Cite
Bahrainian S, Rouini M, Gilani K. Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery. Pharm Dev Technol. 2021;26(6):647-660doi: 10.1080/10837450.2021.1915331.
Bahrainian, S., Rouini, M., & Gilani, K. (2021). Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery. Pharmaceutical development and technology, 26(6), 647-660. https://doi.org/10.1080/10837450.2021.1915331
Bahrainian, Sara, et al. "Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery." Pharmaceutical development and technology vol. 26,6 (2021): 647-660. doi: https://doi.org/10.1080/10837450.2021.1915331
Bahrainian S, Rouini M, Gilani K. Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery. Pharm Dev Technol. 2021 Jul;26(6):647-660. doi: 10.1080/10837450.2021.1915331. Epub 2021 May 05. PMID: 33896355.
Copy Download .nbib Format: NLM
Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination.

Brain pathology (Zurich, Switzerland)

Kleinschmidt-DeMasters BK, Chiang J, Donson AM, Borges T, Gilani A.
PMID: 34297434
Brain Pathol. 2021 Jul 23;e13008. doi: 10.1111/bpa.13008. Epub 2021 Jul 23.

This myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arose in the midbrain tectum rather than in the septum pellucidum, as in the previously-reported cases.

Cite
Kleinschmidt-DeMasters BK, Chiang J, Donson AM, et al. Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination. Brain Pathol. 2021;e13008doi: 10.1111/bpa.13008.
Kleinschmidt-DeMasters, B. K., Chiang, J., Donson, A. M., Borges, T., & Gilani, A. (2021). Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination. Brain pathology (Zurich, Switzerland), e13008. https://doi.org/10.1111/bpa.13008
Kleinschmidt-DeMasters, B K, et al. "Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination." Brain pathology (Zurich, Switzerland) vol. (2021): e13008. doi: https://doi.org/10.1111/bpa.13008
Kleinschmidt-DeMasters BK, Chiang J, Donson AM, Borges T, Gilani A. Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination. Brain Pathol. 2021 Jul 23;e13008. doi: 10.1111/bpa.13008. Epub 2021 Jul 23. PMID: 34297434.
Copy Download .nbib Format: NLM
Showing 217 to 226 of 226 entries